Article Text

Download PDFPDF
The role of antibacterials in women at risk of preterm birth


Preterm birth (delivery before 37 weeks' gestation) is the commonest cause of neonatal mortality and morbidity in developed countries.1 Most of these births occur after spontaneous preterm labour.2 Intrauterine infection (often subclinical) is strongly implicated in the pathophysiology of spontaneous preterm labour.3 Consequently many published trials have assessed antibacterial therapy used with the aim of preventing preterm birth and associated adverse outcomes. Here we review this evidence and guidelines on antibacterial therapy in women at risk of preterm birth.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.